SLC5A2 and hydrops fetalis: However, discontinuing SGLT2 treatments for HF patients should be conducted under strict control, as the need to keep the hold as short as safely possible and to resume early post-op was highlighted, as the beneficial influence of SGLT2 rapidly deteriorates after withdrawal in this group of patients [164].